UBS raised the firm’s price target on ABM to $51 from $45 and keeps a Neutral rating on the shares. ABM’s Q2 results were solid with several segments contributing to the upside and no real negatives, the analyst tells investors in a research note. UBS considers risk/reward balanced.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABM:
- Is ABM a Buy, Before Earnings?
- ABM Named Among Barron’s 100 Most Sustainable Companies for Second Consecutive Year
- Utica University enters ten-year partnership with ABM
- Utica University Selects ABM to Transform Campus-wide Facilities Management
- ABM President and CEO, Scott Salmirs, Awarded Top Spot on Empower Advocates 2024 Role Model List